- Home
- GRWG vs IPSC Comparison
GRWG vs IPSC Comparison
Compare GRWG & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- IPSC
- Stock Information
- Founded
- GRWG 2008
- IPSC 2019
- Country
- GRWG United States
- IPSC United States
- Employees
- GRWG N/A
- IPSC N/A
- Industry
- GRWG RETAIL: Building Materials
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- GRWG Consumer Discretionary
- IPSC Health Care
- Exchange
- GRWG Nasdaq
- IPSC Nasdaq
- Market Cap
- GRWG 82.9M
- IPSC 77.3M
- IPO Year
- GRWG N/A
- IPSC 2021
- Fundamental
- Price
- GRWG $1.37
- IPSC $0.78
- Analyst Decision
- GRWG Hold
- IPSC Strong Buy
- Analyst Count
- GRWG 5
- IPSC 5
- Target Price
- GRWG $2.75
- IPSC $11.00
- AVG Volume (30 Days)
- GRWG 518.8K
- IPSC 553.5K
- Earning Date
- GRWG 03-12-2025
- IPSC 03-13-2025
- Dividend Yield
- GRWG N/A
- IPSC N/A
- EPS Growth
- GRWG N/A
- IPSC N/A
- EPS
- GRWG N/A
- IPSC N/A
- Revenue
- GRWG $200,882,000.00
- IPSC $2,684,000.00
- Revenue This Year
- GRWG N/A
- IPSC $230.51
- Revenue Next Year
- GRWG N/A
- IPSC $31.87
- P/E Ratio
- GRWG N/A
- IPSC N/A
- Revenue Growth
- GRWG N/A
- IPSC 7.88
- 52 Week Low
- GRWG $1.35
- IPSC $0.75
- 52 Week High
- GRWG $3.38
- IPSC $5.51
- Technical
- Relative Strength Index (RSI)
- GRWG 30.12
- IPSC 27.82
- Support Level
- GRWG $1.37
- IPSC $0.78
- Resistance Level
- GRWG $1.46
- IPSC $0.89
- Average True Range (ATR)
- GRWG 0.07
- IPSC 0.07
- MACD
- GRWG -0.01
- IPSC -0.00
- Stochastic Oscillator
- GRWG 3.70
- IPSC 10.30
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.